Center for Food Safety and Applied Nutrition, US Food and Drug Administration, Office of Analytics and Outreach, Division of Public Health Informatics and Analytics, Harvey W. Wiley Building (CPK 1), 5001 Campus Drive, 2C-103, College Park, MD 20740, USA.
Center for Science in the Public Interest, Washington, DC, USA.
Public Health Nutr. 2019 Oct;22(14):2531-2542. doi: 10.1017/S1368980019001605. Epub 2019 Jul 18.
To describe and compare caffeinated energy drink adverse event (AE) report/exposure call data from the US Food and Drug Administration Center for Food Safety and Applied Nutrition's Adverse Event Reporting System (CAERS) and the American Association of Poison Control Centers' National Poison Data System (NPDS).
Cross-sectional.
Data were evaluated from US-based CAERS reports and NPDS exposure calls, including report/exposure call year, age, sex, location, single v. multiple product consumption, outcome, symptom, intentionality (NPDS only), report type, product name (CAERS only).
The analysis defined participants (cases) by the number of caffeinated energy drink products indicated in each AE report or exposure call. Single product cases included 357 from CAERS and 12 822 from NPDS; multiple product cases included 153 from CAERS and 931 from NPDS.
CAERS v. NPDS single product cases were older and more frequently indicated serious symptoms. Multiple v. single product consumers were older in both. In CAERS, unlike NPDS, most multiple product consumers were female. CAERS single v. multiple product reports cited higher proportions of life-threatening events, but less often indicated hospitalization and serious events. NPDS multiple v. single product cases involved fewer ≤5-year-olds and were more often intentional.
Despite limitations, both data sources contribute to post-market surveillance and improve understanding of public health concerns.
描述并比较来自美国食品和药物管理局食品安全与应用营养中心不良事件报告系统(CAERS)和美国毒物控制中心协会国家毒物数据系统(NPDS)的含咖啡因能量饮料不良事件(AE)报告/暴露电话数据。
横断面研究。
评估了来自美国的 CAERS 报告和 NPDS 暴露电话的数据,包括报告/暴露电话年份、年龄、性别、地点、单一产品与多种产品消费、结局、症状、意图(仅 NPDS)、报告类型、产品名称(仅 CAERS)。
分析通过每个 AE 报告或暴露电话中指示的含咖啡因能量饮料产品数量来定义参与者(病例)。单一产品病例包括 CAERS 中的 357 例和 NPDS 中的 12822 例;多产品病例包括 CAERS 中的 153 例和 NPDS 中的 931 例。
与 NPDS 相比,CAERS 中的单一产品病例年龄更大,更频繁地出现严重症状。两种情况下的多产品消费者年龄都更大。在 CAERS 中,与 NPDS 不同,大多数多产品消费者为女性。CAERS 单一产品病例报告中提到的危及生命的事件比例较高,但住院和严重事件的比例较低。NPDS 多产品病例中,5 岁以下儿童较少,且更常为故意摄入。
尽管存在局限性,但这两个数据源都有助于上市后监测,并提高对公共卫生问题的理解。